Ernexa Therapeutics Inc. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for the quarter ending 2020-12-31 was $8.00K, a 0.00% change year-over-year.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for the quarter ending 2020-09-30 was $0.00.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for the quarter ending 2020-06-30 was $8.00K, a 0.00% change year-over-year.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for the quarter ending 2020-03-31 was $0.00.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for fiscal 2020 was $16.00K, a 0.00% change from fiscal 2019.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for fiscal 2019 was $16.00K, a 0.00% change from fiscal 2018.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for fiscal 2018 was $16.00K, a 0.00% change from fiscal 2017.
- Ernexa Therapeutics Inc. stock issued during period, value, stock dividend for fiscal 2017 was $16.00K.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2020-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $16.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $16.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | $8.00K 10-Q · filed 2020-08-07 | $16.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2021-03-11 | $16.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $16.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | |
| 2019-06-30 | $8.00K 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $16.00K 10-K · filed 2020-03-19 | |
| 2017-12-31 | $16.00K 10-K · filed 2019-03-22 | |
| 2016-12-31 | -$16.00K 10-K · filed 2018-03-09 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2011-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $16.00K 10-K · filed 2012-03-30 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | |
| 2010-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $16.00K 10-K · filed 2012-03-30 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |